T2 |
Visible tumor signal is absent. |
|
- Normalization of wall in tumor bed; no detectable mass, nodular intermediate signal, or wall thickening (with individual layers of wall identified again) |
4 |
- mrTRG1†: linear/crescentic thin scar in mucosa/submucosa or apparent normalization of wall in tumor bed |
5 |
- Regular, hypointense scar in inner layer without bulging or breach by intermediate signal and homogeneous intermediate signal in underlying layer of wall in tumor bed |
1 |
- Normalization of wall or hypointense wall (with thickening) without intermediate signal in tumor bed |
5 |
- mrTRG1–2†: mrTRG1 or dense fibrosis with no obvious residual tumor |
4 |
Visible tumor signal may be present in small amount. |
|
- mrTRG1–3†: mrTRG1–2 or > 50% fibrosis or mucin and visible residual intermediate tumor signal |
1 |
- Residual intermediate tumor signal in ≤ 25% of tumor bed |
1 |
Obscure |
3 |
DWI |
No hyperintense signal on high b-value (≥ 800 sec/mm2) DWI in tumor bed |
8 |
Hyperintense signal in ≤ 25% in tumor bed |
1 |
Obscure |
2 |
Combined T2 and DWI‡
|
When both T2 and DWI are negative for residual tumor |
1 |
When both T2 and DWI are negative for residual tumor, with DWI being decisive if T2 findings are equivocal |
2 |
T2 findings as primary results, with DWI to override T2 when T2 findings are equivocal or DWI to increase reader confidence if T2 and DWI findings are consistent |
1 |
Obscure |
4 |